Latent Membrane Protein 1 of Epstein–Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma

(2018) Hailong Ma et al.   BRITISH JOURNAL OF CANCER

Porcine enterocyte protein Btnl5 negatively regulates NF-kappa B pathway by interfering p65 nuclear translocation

(2018) Qi Bao et al.   GENE

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy

(2018) Sandra Iurescia et al.   Recent Patents on Anti-Cancer Drug Discovery

Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)

(2018) James S. Lawson et al.   Frontiers in Oncology

Inhibition of rabies virus replication by interferon-stimulated gene 15 and its activating enzyme UBA7

(2017) Pingsen Zhao et al.   INFECTION GENETICS AND EVOLUTION

The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma

(2017) Jinglin Zhang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway

(2017) Yuanjun Lu et al.   Journal of Innate Immunity

West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5

(2017) Hong-Lei Zhang et al.   JOURNAL OF VIROLOGY

The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy

(2017) Yuanbing Wu et al.   Translational Research

The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I

(2017) Chunyuan Zhao et al.   Cell Reports

RIG-I: a multifunctional protein beyond a pattern recognition receptor

(2017) Xiao-xiao Xu et al.   Protein & Cell

Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses

(2017) Wei Liu et al.   eLife

Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells

(2016) Wei-Wen Sung et al.   CANCER LETTERS

Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs

(2016) Diana Rose E. Ranoa et al.   Oncotarget

Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway

(2015) Yumei Duan et al.   CANCER LETTERS

Cytoplasmic STAT4 Promotes Antiviral Type I IFN Production by Blocking CHIP-Mediated Degradation of RIG-I

(2015) Kai Zhao et al.   JOURNAL OF IMMUNOLOGY

RIG-I Helicase-Independent Pathway in Sendai Virus-Activated Dendritic Cells Is Critical for Preventing Lung Metastasis of AT6.3 Prostate Cancer

(2015) Tomonori Kato et al.   NEOPLASIA

RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells

(2014) P Duewell et al.   CELL DEATH AND DIFFERENTIATION

Therapeutic Efficacy of Bifunctional siRNA Combining TGF- 1 Silencing with RIG-I Activation in Pancreatic Cancer

(2013) J. Ellermeier et al.   CANCER RESEARCH

Induction of Siglec-G by RNA Viruses Inhibits the Innate Immune Response by Promoting RIG-I Degradation

(2013) Weilin Chen et al.   CELL

Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer

(2013) Tsukasa Seya et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma

(2013) Martin Glas et al.   STEM CELLS

The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis

(2013) Yasufumi Kaneda   OncoImmunology

TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles

(2012) T. Matsushima-Miyagi et al.   CLINICAL CANCER RESEARCH

A structure-based model of RIG-I activation

(2012) D. Kolakofsky et al.   RNA

Degradation of RIG-I following cytomegalovirus infection is independent of apoptosis

(2009) Iain Scott   MICROBES AND INFECTION

5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

(2008) Hendrik Poeck et al.   NATURE MEDICINE

Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling

(2008) M Samanta et al.   ONCOGENE